2-[(3-bromo-2-oxo-1H-quinolin-6-yl)oxy]-N-[(1E)-1-methoxyimino-2-methylpropan-2-yl]-2-methylsulfanylacetamide

C17H20BrN3O4S — CID 140557262

IUPAC2-[(3-bromo-2-oxo-1H-quinolin-6-yl)oxy]-N-[(1E)-1-methoxyimino-2-methylpropan-2-yl]-2-methylsulfanylacetamide
SMILESCO/N=C/C(C)(C)NC(=O)C(Oc1ccc2[nH]c(=O)c(Br)cc2c1)SC
InChIInChI=1S/C17H20BrN3O4S/c1-17(2,9-19-24-3)21-15(23)16(26-4)25-11-5-6-13-10(7-11)8-12(18)14(22)20-13/h5-9,16H,1-4H3,(H,20,22)(H,21,23)/b19-9+
InChIKeyPHESDMPOIHEYJG-DJKKODMXSA-N
MW442.34 g/mol
LogP2.89
Rot. Bonds7

About 2-[(3-bromo-2-oxo-1H-quinolin-6-yl)oxy]-N-[(1E)-1-methoxyimino-2-methylpropan-2-yl]-2-methylsulfanylacetamide

2-[(3-bromo-2-oxo-1H-quinolin-6-yl)oxy]-N-[(1E)-1-methoxyimino-2-methylpropan-2-yl]-2-methylsulfanylacetamide (PubChem CID 140557262) has the molecular formula C17H20BrN3O4S and a molecular weight of 442.34 g/mol. Its IUPAC name is 2-[(3-bromo-2-oxo-1H-quinolin-6-yl)oxy]-N-[(1E)-1-methoxyimino-2-methylpropan-2-yl]-2-methylsulfanylacetamide.

Molecular Properties

Compound Name2-[(3-bromo-2-oxo-1H-quinolin-6-yl)oxy]-N-[(1E)-1-methoxyimino-2-methylpropan-2-yl]-2-methylsulfanylacetamide
PubChem CID140557262
Molecular FormulaC17H20BrN3O4S
Molecular Weight442.34 g/mol
Exact Mass441.04
IUPAC Name2-[(3-bromo-2-oxo-1H-quinolin-6-yl)oxy]-N-[(1E)-1-methoxyimino-2-methylpropan-2-yl]-2-methylsulfanylacetamide
SMILESCO/N=C/C(C)(C)NC(=O)C(Oc1ccc2[nH]c(=O)c(Br)cc2c1)SC
InChIInChI=1S/C17H20BrN3O4S/c1-17(2,9-19-24-3)21-15(23)16(26-4)25-11-5-6-13-10(7-11)8-12(18)14(22)20-13/h5-9,16H,1-4H3,(H,20,22)(H,21,23)/b19-9+
InChIKeyPHESDMPOIHEYJG-DJKKODMXSA-N
XLogP2.89
TPSA92.78 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds7
Heavy Atoms26
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500442.34
LogP ≤ 52.89
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 2-[(3-bromo-2-oxo-1H-quinolin-6-yl)oxy]-N-[(1E)-1-methoxyimino-2-methylpropan-2-yl]-2-methylsulfanylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[(3-bromo-2-oxo-1H-quinolin-6-yl)oxy]-N-[(1E)-1-methoxyimino-2-methylpropan-2-yl]-2-methylsulfanylacetamide?
The IUPAC name of 2-[(3-bromo-2-oxo-1H-quinolin-6-yl)oxy]-N-[(1E)-1-methoxyimino-2-methylpropan-2-yl]-2-methylsulfanylacetamide (CID 140557262) is 2-[(3-bromo-2-oxo-1H-quinolin-6-yl)oxy]-N-[(1E)-1-methoxyimino-2-methylpropan-2-yl]-2-methylsulfanylacetamide.
What is the SMILES notation for 2-[(3-bromo-2-oxo-1H-quinolin-6-yl)oxy]-N-[(1E)-1-methoxyimino-2-methylpropan-2-yl]-2-methylsulfanylacetamide?
The canonical SMILES for 2-[(3-bromo-2-oxo-1H-quinolin-6-yl)oxy]-N-[(1E)-1-methoxyimino-2-methylpropan-2-yl]-2-methylsulfanylacetamide is CO/N=C/C(C)(C)NC(=O)C(Oc1ccc2[nH]c(=O)c(Br)cc2c1)SC.
What is the InChIKey of 2-[(3-bromo-2-oxo-1H-quinolin-6-yl)oxy]-N-[(1E)-1-methoxyimino-2-methylpropan-2-yl]-2-methylsulfanylacetamide?
The InChIKey is PHESDMPOIHEYJG-DJKKODMXSA-N. The full InChI is InChI=1S/C17H20BrN3O4S/c1-17(2,9-19-24-3)21-15(23)16(26-4)25-11-5-6-13-10(7-11)8-12(18)14(22)20-13/h5-9,16H,1-4H3,(H,20,22)(H,21,23)/b19-9+.
What are the key properties of 2-[(3-bromo-2-oxo-1H-quinolin-6-yl)oxy]-N-[(1E)-1-methoxyimino-2-methylpropan-2-yl]-2-methylsulfanylacetamide?
2-[(3-bromo-2-oxo-1H-quinolin-6-yl)oxy]-N-[(1E)-1-methoxyimino-2-methylpropan-2-yl]-2-methylsulfanylacetamide has a molecular weight of 442.34 g/mol, XLogP of 2.89, 7 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(3-bromo-2-oxo-1H-quinolin-6-yl)oxy]-N-[(1E)-1-methoxyimino-2-methylpropan-2-yl]-2-methylsulfanylacetamide is sourced from PubChem (CID 140557262), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).